Vontobel Holding
DNA icon

Vontobel Holding’s Ginkgo Bioworks DNA Stock Holding History

Vontobel Holding’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,125
Closed -$76K – 1113
2023
Q4 		$76K Hold
1,125
– – ﹤0.01% 1053
2023
Q3 		$81.5K Buy
1,125
+550
+96% +$44K ﹤0.01% 1028
2023
Q2 		$42.8K Buy
575
+125
+28% +$7.4K ﹤0.01% 1077
2023
Q1 		$23.9K Buy
450
+125
+38% +$7.92K ﹤0.01% 1059
2022
Q4 		$22K Buy
+325
New +$29.9K ﹤0.01% 1078
2022
Q2 		– Sell
-653
Closed -$105K – 1045
2022
Q1 		$105K Buy
+653
New +$127K ﹤0.01% 1034

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vontobel Holding's DNA Position: Q1 2024 in Review

Vontobel Holding sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 1,125 shares — an estimated $76K sold.

Vontobel Holding first reported a position in DNA in Q1 2022 and held it in 6 quarters. The position peaked at $105K in Q1 2022. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Vontobel Holding reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Vontobel Holding sold 1,125 Ginkgo Bioworks shares in Q1 2024, an estimated $76K.
  • Vontobel Holding first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 6 quarters.
  • Vontobel Holding's Ginkgo Bioworks position peaked at $105K in Q1 2022.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Vontobel Holding's 13F filing for Q1 2024, filed 10 May 2024.